Security record · archived quarter
ABUS
Arbutus Biopharma Corp · Healthcare · Biotechnology
9Tracked holders
0Δ holders
11.43MShares held
$37.37MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -11.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +3 | 78.82M | $378.29M | +13 | −10 |
| Q1 2026 | 75 | -5 | 80.64M | $362.88M | +5 | −10 |
| Q4 2025 | 79 | -1 | 77.73M | $373.87M | — | −1 |
| Q3 2025 | 16 | 0 | 63.04M | $286.21M | +1 | −1 |
| Q2 2025 | 13 | +1 | 34.03M | $105.14M | +1 | — |
| Q1 2025 | 9 | 0 | 10.62M | $37.08M | — | — |
| Q4 2024 | 9 | 0 | 11.43M | $37.37M | — | — |
| Q3 2024 | 8 | +1 | 7.82M | $30.10M | +1 | — |
| Q2 2024 | 7 | — | 7.20M | $22.26M | — | — |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 5.03M | — | $16.44M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.48M | +1.0% | $11.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.48M | +1.0% | $11.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Adage Capital Partners ✦ | 1.65M | -43.1% | $5.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 513.30K | +3.3% | $1.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 513.30K | +3.3% | $1.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Millennium Management ✦ | 343.03K | +36.7% | $1.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 277.56K | -54.3% | $907,618 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 56.45K | +18.1% | $185,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 48.72K | +44.5% | $159,327 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 48.72K | +44.5% | $159,327 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 48.72K | +44.5% | $159,327 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 48.72K | +44.5% | $159,327 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 29.49K | -0.8% | $96,419 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 166 holders, 138.84M shares, $623.91M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API